Atlas Trials

This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever

Clinical trial NCT07445282 · COMPLETED

Trial details

NCT number
NCT07445282
Sponsor
Sheikh Zayed Medical College
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Extensively Drug-Resistant Typhoid FeverTyphoid FeverSalmonella Typhi Infection
Start date
2025-05-14
Primary completion
2025-11-14
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.